1
/
of
1
Ezitin (Ezetimibe)
Ezitin (Ezetimibe)
Regular price
₱1,904.00 PHP
Regular price
Sale price
₱1,904.00 PHP
Unit price
₱27.20 each
Taxes included.
Quantity
Couldn't load pickup availability
Ezitin (Ezetimibe) is a prescription lipid-lowering medication designed to reduce elevated LDL cholesterol levels in patients with hypercholesterolemia and related lipid disorders. This oral medication works through a unique mechanism distinct from statins—it acts in the small intestine to inhibit the absorption of cholesterol from dietary sources and bile, preventing it from entering the bloodstream. By blocking the NPC1L1 protein in the gut, ezetimibe effectively lowers LDL cholesterol, total cholesterol, and triglyceride levels.
Ezitin is indicated for primary hypercholesterolemia, familial hypercholesterolemia, mixed dyslipidemia, and sitosterolemia. It is particularly valuable for patients who are intolerant to high-dose statins or require additional LDL reduction despite existing statin therapy. Major clinical guidelines recommend ezetimibe as add-on therapy for high-risk patients, including those with atherosclerotic cardiovascular disease, diabetes, or familial hypercholesterolemia. When combined with statins such as atorvastatin or simvastatin, it provides complementary cholesterol-lowering effects that diet and exercise alone may not achieve.
The standard adult dose is one 10 mg oral tablet taken once daily, with or without food. For optimal results, take it at the same time each day as part of a comprehensive approach that includes a low-fat diet, regular physical activity, and weight management. Ezetimibe is generally well tolerated with a low incidence of muscle-related side effects, making it suitable for long-term cholesterol management and cardiovascular risk reduction in eligible patients. Always use this medication under the guidance of a healthcare provider and maintain regular monitoring of lipid profiles to assess efficacy.
Ezitin is indicated for primary hypercholesterolemia, familial hypercholesterolemia, mixed dyslipidemia, and sitosterolemia. It is particularly valuable for patients who are intolerant to high-dose statins or require additional LDL reduction despite existing statin therapy. Major clinical guidelines recommend ezetimibe as add-on therapy for high-risk patients, including those with atherosclerotic cardiovascular disease, diabetes, or familial hypercholesterolemia. When combined with statins such as atorvastatin or simvastatin, it provides complementary cholesterol-lowering effects that diet and exercise alone may not achieve.
The standard adult dose is one 10 mg oral tablet taken once daily, with or without food. For optimal results, take it at the same time each day as part of a comprehensive approach that includes a low-fat diet, regular physical activity, and weight management. Ezetimibe is generally well tolerated with a low incidence of muscle-related side effects, making it suitable for long-term cholesterol management and cardiovascular risk reduction in eligible patients. Always use this medication under the guidance of a healthcare provider and maintain regular monitoring of lipid profiles to assess efficacy.
Share
